Advench Pharmaceutical Private Limited

Feature -

• Type: Combination vaccine (hexavalent).
• Composition: Protects against six diseases – Diphtheria, Tetanus, Pertussis (whooping cough), Hepatitis B, Poliomyelitis, and Haemophilus influenzae type b (Hib).
• Dosage Form: Injectable suspension for intramuscular use.
• Age Group: Recommended for infants and young children (from 6 weeks to 24 months of age).
• Schedule: Administered in a series of primary doses (usually at 6, 10, and 14 weeks) followed by a booster as per national immunization guidelines.
• Administration Site: Anterolateral thigh muscle in infants; deltoid in older children.
• Benefits: Provides broad-spectrum protection in a single injection, reducing the number of separate shots.

Bevac Vaccine is a high-quality Hepatitis B vaccine designed to provide active immunity against Hepatitis B virus (HBV) infection. It is formulated using advanced recombinant DNA technology to ensure safety, potency, and consistent immunogenic response. Bevac Vaccine helps prevent Hepatitis B, a serious liver infection that can lead to chronic liver disease, cirrhosis, or liver cancer.